13F filer · CIK 1643354
Lion Point Capital, LP
NEW YORK, NY · filing since Q4 2015 · last filing Aug 14, 2026
Reported value
$20.9M
+$4.2M vs prior
Positions
35
New / sold out
1 / 1
Added / reduced
0 / 0
Turnover
2.7%
buys $1.7M · sells $506.4K
Top-10 weight
55.0%
Biggest buys vs Q1 2026
| Change | Security | Shares change | Change % | Est. trade value |
|---|---|---|---|---|
| New | CUE BIOPHARMA INC | +52,928 | – | +$1.7M |
Biggest sells vs Q1 2026
| Change | Security | Shares change | Change % | Est. trade value |
|---|---|---|---|---|
| Sold out | CUE BIOPHARMA INC | -2,202,854 | -100.0% | $-506.4K |
Estimated trade value = change in shares × this quarter's implied price. 13F filings show quarter-end positions, not individual trades.
Reported value by quarter
Holdings · Q2 2026
| # | Security | Shares | Value | Weight |
|---|---|---|---|---|
| 1 | CUE BIOPHARMA INCCOM | 52,928 | $1.7M | 7.99% |
| 2 | PRAXIS PRECISION MEDICINES ICOM NEW | 4,450 | $1.5M | 7.13% |
| 3 | MOONLAKE IMMUNOTHERAPEUTICSCLASS A ORD | 67,500 | $1.3M | 6.29% |
| 4 | FENNEC PHARMACEUTICALS INCCOM | 112,434 | $1.2M | 5.78% |
| 5 | ROYALTY PHARMA PLCSHS CLASS A | 21,400 | $1.2M | 5.74% |
| 6 | COMPASS PATHWAYS PLCSPONSORED ADS | 80,000 | $1.1M | 5.41% |
| 7 | MILESTONE PHARMACEUTICALS INCOM | 820,000 | $1.1M | 5.26% |
| 8 | BENITEC BIOPHARMA INCCOM NEW | 62,000 | $829.6K | 3.97% |
| 9 | SYNDAX PHARMACEUTICALS INCCOM | 36,000 | $787.0K | 3.76% |
| 10 | BIOHAVEN LTDCOM | 51,700 | $769.3K | 3.68% |
25 more rows. Subscribe for $29/month to see every row, download the data and use the API.